Podcast

A Long History of BRCA

Author(s):

This week, we spoke with three sisters with a long family history of the BRCA gene mutation – one that dates back to 1860 in Poland.

Dating back to 1860 in Poland, three sisters’ journeys with the BRCA mutation isn’t exactly the claim to fame they were hoping for.

Kathryn (Winn) Buckley, Bridget (Winn) Stillwell and Maureen (Winn) Boesen’s family was one of eight studied at Creighton University in the 1980s, and at one point, the most significant history of breast and ovarian cancer ever documented in the United States.

As they prepare for their book, titled “Nipples Optional,” to come out next year, the sisters sat down with CURE Talks Cancer to walk us through their family health history. They also discussed how the BRCA mutation has affected their lives and how they’ve talked about their family health history with their children.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Related Content